Royalty Pharma plc (RPRX) Tops Q2 Revenue Estimate
Go back to Royalty Pharma plc (RPRX) Tops Q2 Revenue Estimate| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 58.05 -1.17 (1.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.22 | 52 Week High | $3.48 | |||
| Open | $59.50 | 52 Week Low | $0.80 | |||
| Day High | $59.58 | P/E | N/A | |||
| Day Low | $58.04 | EPS | $-1.54 | |||
| Volume | 1,256,202 | |||||

